Ophthalmology · San Diego, CA
NPI
1306016696
Since 2008
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4405 Vandever Ave
San Diego, CA, 92120
Phone (619) 516-7140
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$242K
3,141 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Alexander K Nugent prescribed most often to Medicare patients was Latanoprost, with 910 prescriptions and refills. In total Alexander K Nugent wrote 3,141 Medicare prescriptions that cost $242K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Latanoprost Generic | 910 | 2,711 | 370 | $14K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 673 | 2,149 | 240 | $18K |
| Brimonidine Tartrate Generic | 331 | 1,013 | 127 | $8,183 |
| Prednisolone Acetate Generic | 197 | 312 | 92 | $8,420 |
| Timolol Maleate Generic | 175 | 563 | 67 | $2,811 |
| Bimatoprost Generic | 154 | 500 | 75 | $18K |
| Dorzolamide Hcl Generic | 138 | 406 | 48 | $3,823 |
| Cyclosporine Generic | 77 | 144 | 24 | $14K |
| Tafluprost Tafluprost/Pf | 67 | 162 | 26 | $26K |
| Brinzolamide Generic | 48 | 123 | 18 | $18K |
| Rhopressa Netarsudil Mesylate | 47 | 132 | 24 | $52K |
| Dorzolamide-Timolol Dorzolamide/Timolol/Pf | 41 | 84 | 13 | $7,306 |
| Pilocarpine Hcl Generic | 35 | 117 | 14 | $1,857 |
| Moxifloxacin Moxifloxacin Hcl | 32 | 57 | 15 | $541 |
| Ketorolac Tromethamine Generic | 32 | 32 | Under 11 | $429 |
Brand drugs: 514 claims; generic drugs: 2,627 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Alexander K Nugent were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.